Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
Top Cited Papers
Open Access
- 13 February 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 31 (4), 478-492
- https://doi.org/10.1007/s11239-011-0551-3
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip ReplacementThe New England Journal of Medicine, 2010
- Apixaban inhibition of factor Xa: Microscopic rate constants and inhibition mechanism in purified protein systems and in human plasmaJournal of Enzyme Inhibition and Medicinal Chemistry, 2010
- Clinical burden of venous thromboembolismCurrent Medical Research and Opinion, 2010
- Effect of the Direct Factor Xa Inhibitor Apixaban in Rat Models of Thrombosis and HemostasisJournal of Cardiovascular Pharmacology, 2010
- Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombinThrombosis and Haemostasis, 2010
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee ReplacementThe New England Journal of Medicine, 2009
- Sulfation of O-Demethyl Apixaban: Enzyme Identification and Species ComparisonDrug Metabolism and Disposition, 2009
- Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbitsJournal of Thrombosis and Haemostasis, 2008
- Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- 1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor XaBioorganic & Medicinal Chemistry Letters, 2006